C149H125F17N26O10S — CID 158263184
3-[(4-acetamidopyrimidin-2-yl)amino]-4-methyl-N-[3-(3-methylpyrrol-1-yl)-5-(trifluoromethyl)phenyl]benzamide;N-[3-(1,1-difluoroethyl)phenyl]-4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamide;4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]benzamide;4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-phenoxybenzamide;4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-phenylmethoxybenzamide;4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-phenylpyrimidin-2-yl)amino]benzenesulfonamide (PubChem CID 158263184) has the molecular formula C149H125F17N26O10S and a molecular weight of 2794.84 g/mol. Its IUPAC name is 3-[(4-acetamidopyrimidin-2-yl)amino]-4-methyl-N-[3-(3-methylpyrrol-1-yl)-5-(trifluoromethyl)phenyl]benzamide;N-[3-(1,1-difluoroethyl)phenyl]-4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamide;4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]benzamide;4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-phenoxybenzamide;4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-phenylmethoxybenzamide;4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-phenylpyrimidin-2-yl)amino]benzenesulfonamide.
| Compound Name | 3-[(4-acetamidopyrimidin-2-yl)amino]-4-methyl-N-[3-(3-methylpyrrol-1-yl)-5-(trifluoromethyl)phenyl]benzamide;N-[3-(1,1-difluoroethyl)phenyl]-4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamide;4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]benzamide;4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-phenoxybenzamide;4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-phenylmethoxybenzamide;4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-phenylpyrimidin-2-yl)amino]benzenesulfonamide |
|---|---|
| PubChem CID | 158263184 |
| Molecular Formula | C149H125F17N26O10S |
| Molecular Weight | 2794.84 g/mol |
| Exact Mass | 2792.95 |
| IUPAC Name | 3-[(4-acetamidopyrimidin-2-yl)amino]-4-methyl-N-[3-(3-methylpyrrol-1-yl)-5-(trifluoromethyl)phenyl]benzamide;N-[3-(1,1-difluoroethyl)phenyl]-4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamide;4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]benzamide;4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-phenoxybenzamide;4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-phenylmethoxybenzamide;4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-phenylpyrimidin-2-yl)amino]benzenesulfonamide |
| SMILES | CC(=O)Nc1ccnc(Nc2cc(C(=O)Nc3cc(-n4ccc(C)c4)cc(C(F)(F)F)c3)ccc2C)n1.Cc1ccc(C(=O)Nc2cc(-n3cnc(C)c3)cc(C(F)(F)F)c2)cc1.Cc1ccc(C(=O)Nc2cccc(C(C)(F)F)c2)cc1Nc1nccc(-c2cccnc2)n1.Cc1cn(-c2cc(NC(=O)c3ccc(C)c(OCc4ccccc4)c3)cc(C(F)(F)F)c2)cn1.Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Oc4ccccc4)c3)cc(C(F)(F)F)c2)cn1.Cc1cn(-c2cc(NS(=O)(=O)c3ccc(C)c(Nc4nccc(-c5ccccc5)n4)c3)cc(C(F)(F)F)c2)cn1 |
| InChI | InChI=1S/C28H23F3N6O2S.C26H23F3N6O2.C26H22F3N3O2.C25H20F3N3O2.C25H21F2N5O.C19H16F3N3O/c1-18-8-9-24(15-26(18)35-27-32-11-10-25(34-27)20-6-4-3-5-7-20)40(38,39)36-22-12-21(28(29,30)31)13-23(14-22)37-16-19(2)33-17-37;1-15-7-9-35(14-15)21-12-19(26(27,28)29)11-20(13-21)32-24(37)18-5-4-16(2)22(10-18)33-25-30-8-6-23(34-25)31-17(3)36;1-17-8-9-20(10-24(17)34-15-19-6-4-3-5-7-19)25(33)31-22-11-21(26(27,28)29)12-23(13-22)32-14-18(2)30-16-32;1-16-8-9-18(10-23(16)33-22-6-4-3-5-7-22)24(32)30-20-11-19(25(26,27)28)12-21(13-20)31-14-17(2)29-15-31;1-16-8-9-17(23(33)30-20-7-3-6-19(14-20)25(2,26)27)13-22(16)32-24-29-12-10-21(31-24)18-5-4-11-28-15-18;1-12-3-5-14(6-4-12)18(26)24-16-7-15(19(20,21)22)8-17(9-16)25-10-13(2)23-11-25/h3-17,36H,1-2H3,(H,32,34,35);4-14H,1-3H3,(H,32,37)(H2,30,31,33,34,36);3-14,16H,15H2,1-2H3,(H,31,33);3-15H,1-2H3,(H,30,32);3-15H,1-2H3,(H,30,33)(H,29,31,32);3-11H,1-2H3,(H,24,26) |
| InChIKey | GICWAAOJVJNCHA-UHFFFAOYSA-N |
| XLogP | 35.97 |
| TPSA | 441.76 Ų |
| H-Bond Donors | 10 |
| H-Bond Acceptors | 29 |
| Rotatable Bonds | 33 |
| Heavy Atoms | 203 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2794.84 |
| LogP ≤ 5 | 35.97 |
| H-Bond Donors ≤ 5 | 10 |
| H-Bond Acceptors ≤ 10 | 29 |